youtube_live
Q1 2027 earnings • in 4 days
See detailschevron_right
CAH:NYSE
Cardinal Health, Inc
$250.48
arrow_downward
-0.24%(-0.61) 1D
$250.01
arrow_downward
-0.19% (-0.47)bedtimeAfter hours
Closed: Oct 30, 3:00:07 PM GMT-5 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CAH...
Open
$255.02
High
$259.84
Low
$250.12
Mkt. cap
58.00B
Avg. vol.
1.84M
Volume
1.95M
Dividend
0.82%
Quarterly dividend
$0.52
Ex-dividend date
Oct 1, 2026
P/E ratio
34.63
52-wk high
$259.84
52-wk low
$180.45
EPS
$7.23
Beta
0.50
Shares outstanding
231.56M
No. of employees
61K
Open
$255.02
High
$259.84
Low
$250.12
Mkt. cap
58.00B
Avg. vol.
1.84M
Volume
1.95M
Dividend
0.82%
Quarterly dividend
$0.52
Ex-dividend date
Oct 1, 2026
P/E ratio
34.63
52-wk high
$259.84
52-wk low
$180.45
EPS
$7.23
Beta
0.50
Shares outstanding
231.56M
No. of employees
61K
News stories
From web sources and news partners
Trefis
·
2 days ago
Is It A Mistake To Buy Cardinal Health Stock At A High?
Profile
Cardinal Health Technologies, LLC doing business as Cardinal Health, is an American multinational health care services company, and the 15th highest revenue generating company in the United States. Headquartered in Dublin, Ohio, the company specializes in the distribution of pharmaceuticals and medical products, serving more than 100,000 locations. The company also manufactures medical and surgical product, including gloves, surgical apparel, and fluid management products. In addition, it operates one of the largest networks of radiopharmacies in the U.S. Cardinal Health provides medical products to over 75 percent of hospitals in the United States. Wikipedia
About Cardinal Health, Inc
CEOJason Hollar
Employees61.3K
Founded1971
HeadquartersDublin, Ohio, United States
SectorHealth care provider
Websitecardinalhealth.com
Analyst ratings
Based on 13 analysts giving stock ratings to CAH in the past 3 months
Strong buy
Buy
11
Hold
2
Sell
0
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for CAH in the last 3 months.
Highest
Current $250.48
$295.00 (+17.77%)
Average
$277.67 (+10.86%)
Lowest
$260.00 (+3.80%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Erin Wright Morgan Stanley | Buy | Reiterated | $286.00 | +14.2% | 10/30/2026 |
Glen Santangelo Barclays | Buy | Maintained | $275.00 | +9.8% | 10/27/2026 |
Steven Valiquette Mizuho Securities | Buy | Maintained | $280.00 | +11.8% | 10/20/2026 |
Kevin Caliendo UBS | Buy | Maintained | $295.00 | +17.8% | 10/16/2026 |
Ryan Halsted RBC Capital | Buy | Maintained | $276.00 | +10.2% | 10/12/2026 |
Stephen Baxter Wells Fargo | Buy | Maintained | $277.00 | +10.6% | 09/09/2026 |
Lisa Gill J.P. Morgan | Hold | Maintained | $260.00 | +3.8% | 08/17/2026 |
George Hill Deutsche Bank | Hold | Maintained | $261.00 | +4.2% | 08/13/2026 |
Charles Rhyee TD Cowen | Buy | Reiterated | $280.00 | +11.8% | 08/13/2026 |
Elizabeth Anderson CFA Evercore ISI | Buy | Maintained | $270.00 | +7.8% | 08/12/2026 |
Daniel Grosslight Citi | Buy | Maintained | $280.00 | +11.8% | 08/12/2026 |
Unknown Analyst Wells Fargo | Buy | Reiterated | $277.00 | +10.6% | 08/12/2026 |
Michael Cherny Leerink Partners | Buy | Maintained | $292.00 | +16.6% | 08/11/2026 |
Ryan Daniels William Blair | Buy | Reiterated | - | - | 08/11/2026 |
Allen Lutz Bank of America Securities | Buy | Maintained | $260.00 | +3.8% | 07/20/2026 |
Unknown Analyst William O'Neil | Buy | Initiated | - | - | 06/12/2026 |
Unknown Analyst Argus Research | Buy | Maintained | $248.00 | -1% | 05/05/2026 |
Steven Silver Argus Research | Buy | Maintained | $248.00 | -1% | 05/05/2026 |
Eric Coldwell Robert W. Baird | Buy | Maintained | $248.00 | -1% | 05/01/2026 |
Max Smock William Blair | Buy | Initiated | - | - | 04/28/2026 |
Next call in 4 days
Thu, Nov 5, 3:30 PM
Fiscal period
Q1 2027
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
- / $2.94
Revenue / Est. (USD)
- / 66.51B
Fiscal Q1 2027 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 64.01B | 65.63B | 60.94B | 63.67B |
Cost of goods sold | 61.69B | 63.23B | 58.44B | 61.11B |
Cost of revenue | 61.69B | 63.23B | 58.44B | 61.11B |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 1.46B | 1.50B | 1.54B | 1.62B |
Operating expense | 1.55B | 1.59B | 1.64B | 1.71B |
Total operating expenses | 63.24B | 64.82B | 60.08B | 62.82B |
Operating income | 771.00M | 809.00M | 861.00M | 847.00M |
Other non operating income | 10.00M | 11.00M | -16.00M | 30.00M |
EBT including unusual items | 598.00M | 630.00M | 392.00M | 554.00M |
EBT excluding unusual items | 701.00M | 732.00M | 744.00M | 794.00M |
Income tax expense | 144.00M | 159.00M | 12.00M | 154.00M |
Effective tax rate | 24.08% | 25.24% | 3.06% | 27.80% |
Other operating expenses | - | - | - | - |
Net income | 450.00M | 467.00M | 399.00M | 398.00M |
Net profit margin | 0.70% | 0.71% | 0.65% | 0.62% |
Earnings per share | 2.55 | 2.63 | 3.17 | 2.60 |
Interest and investment income | - | - | - | - |
Interest expense | -80.00M | -88.00M | -101.00M | -103.00M |
Net interest expenses | -80.00M | -88.00M | -101.00M | -103.00M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 1.00B | 1.04B | 1.11B | 1.09B |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1
Upcoming events